Edition:
United States

LBT Innovations Ltd (LBT.AX)

LBT.AX on Australia Stock Exchange

0.31AUD
1 May 2017
Change (% chg)

$-0.01 (-3.08%)
Prev Close
$0.32
Open
$0.31
Day's High
$0.31
Day's Low
$0.31
Volume
58,131
Avg. Vol
364,624
52-wk High
$1.09
52-wk Low
$0.13

Latest Key Developments (Source: Significant Developments)

LBT Innovations says US FDA grants approval for co's Automated Plate Assessment System
Sunday, 9 Oct 2016 05:30pm EDT 

LBT Innovations Ltd :Clever culture systems received clearance of its 510(k) de novo submission to US FDA for APAS® as a class II medical device..  Full Article

LBT Innovations appoints Brent Barnes as CEO
Sunday, 8 May 2016 11:12pm EDT 

LBT Innovations Ltd : Cochlear executive Brent Barnes appointed CEO of LBT . Brent Barnes appointed CEO of Adelaide-based technology developer LBT Innovations Limited . Says Barnes will begin his tenure on 8 August and will replace Lusia Guthrie, who has been CEO of LBT Innovations .  Full Article

LBT Innovations Ltd's CEO retires
Sunday, 11 Oct 2015 11:32pm EDT 

LBT Innovations Ltd:Says chief executive officer, Lusia Guthrie, will retire from the company as CEO in 2016.Says the company is now in the process of recruiting a new CEO.  Full Article

LBT Innovations signs agreement with Biomerieux
Wednesday, 26 Aug 2015 06:58pm EDT 

LBT Innovations Ltd:Says agreement terminates the initial exclusive license signed in 2007.Says LBT Innovations will receive a one-time, full and final upfront payment of US$5.5 million.Says license agreement with BioméRieux for Lbt'S culture plate-streaking technology, microstreak.Under the new license BioméRieux will retain the sole rights to service and support the installed base of previ isola systems.  Full Article

More From Around the Web

BRIEF-LBT Innovations requests trading halt

* LBT Innovations ltd requests trading halt pending an announcement in relation to a capital raising to market Source text for Eikon: Further company coverage:

No consensus analysis data available.